Mirena - Medsafe
MIRENA® CMI 1 MIRENA® (Mi·RAY·na) levonorgestrel. intrauterine delivery system Consumer Medicine Information . WHAT IS IN THIS LEAFLET This leaflet answers some
Download Mirena - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
The Logistics Handbook - WHO
apps.who.intThe Logistics Handbook A Practical Guide for the Supply Chain Management of Health Commodities 2011 . This publication was produced for review by the U.S. Agency for International Development.
Floseal Hemostatic Matrix ENG
floseal.comFloseal Hemostatic Matrix. Instructions for Use . DO NOT INJECT INTRAVASCULARLY. FLOSEAL Hemostatic Matrix (“FLOSEAL”) must not be injected into
ESSENTIAL MEDICINES LIST - Federal Ministry of Health
health.gov.ngf ederalr epublico f n igeria essential medicines list 5th revision 2010 published by the federal ministry of health abuja, nigeria in collaboration with world health organization and european commission
European Medicines Agency Evaluation of Medicines for ...
www.ema.europa.euEuropean Medicines Agency Evaluation of Medicines for Human Use 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel: (44-20) 74 18 84 00, Fax: (44-20) 75 23 70 40
1. PRODUCT NAME - Medsafe
www.medsafe.govt.nzPRED FORTE® (prednisolone acetate) 1.0% w/v Datasheet Version 3.0 1 NEW ZEALAND DATA SHEET 1. PRODUCT NAME PRED FORTE® 1.0% w/v ophthalmic suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Prednisolone acetate 1.0% w/v (microfine suspension) For the full list of excipients, see section 6.1.
Guideline for the labelling of medicines
www.tga.gov.auGuideline for the labelling medicines of istorical consultation document Draft - Version 1.0, August 2014
Key Indicator Report - Statistics South Africa
www.statssa.gov.zaSouth Africa Demographic and Health Survey 2016: Key Indicator Report, Statistics South Africa Published by Statistics South Africa, Private Bag X44, Pretoria 0001